Barclays Has Lowered Expectations for Allegion (NYSE:ALLE) Stock Price

Allegion (NYSE:ALLE) had its price objective dropped by investment analysts at Barclays from $137.00 to $134.00 in a report issued on Wednesday,Benzinga reports. The firm presently has an “underweight” rating on the scientific and technical instruments company’s stock. Barclays‘s target price indicates a potential upside of 4.34% from the stock’s previous close.

A number of other equities analysts have also commented on the stock. Mizuho raised their price objective on shares of Allegion from $135.00 to $150.00 and gave the stock a “neutral” rating in a research note on Thursday, October 17th. Robert W. Baird raised their target price on Allegion from $145.00 to $152.00 and gave the stock a “neutral” rating in a research report on Friday, October 25th. Wells Fargo & Company dropped their price target on Allegion from $152.00 to $140.00 and set an “equal weight” rating on the stock in a research report on Tuesday. Finally, Morgan Stanley initiated coverage on Allegion in a research report on Monday. They set an “equal weight” rating and a $137.00 price objective for the company. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and one has given a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $140.83.

Allegion Stock Up 0.8 %

Shares of Allegion stock opened at $128.43 on Wednesday. Allegion has a 12-month low of $113.27 and a 12-month high of $156.10. The firm has a market capitalization of $11.16 billion, a PE ratio of 19.73, a price-to-earnings-growth ratio of 3.35 and a beta of 1.11. The company has a quick ratio of 1.29, a current ratio of 1.71 and a debt-to-equity ratio of 1.26. The stock’s fifty day moving average is $137.44 and its 200-day moving average is $135.75.

Allegion (NYSE:ALLE) last posted its quarterly earnings data on Thursday, October 24th. The scientific and technical instruments company reported $2.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.98 by $0.18. Allegion had a return on equity of 45.64% and a net margin of 15.36%. The firm had revenue of $967.10 million for the quarter, compared to the consensus estimate of $970.70 million. During the same quarter in the previous year, the company earned $1.94 EPS. The business’s revenue for the quarter was up 5.4% compared to the same quarter last year. Equities analysts anticipate that Allegion will post 7.41 earnings per share for the current year.

Insider Buying and Selling at Allegion

In other Allegion news, SVP Robert C. Martens sold 8,035 shares of the stock in a transaction on Friday, October 25th. The shares were sold at an average price of $144.92, for a total transaction of $1,164,432.20. Following the transaction, the senior vice president now directly owns 7,104 shares of the company’s stock, valued at $1,029,511.68. This represents a 53.07 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO John H. Stone purchased 7,500 shares of Allegion stock in a transaction on Tuesday, December 3rd. The stock was bought at an average cost of $140.70 per share, with a total value of $1,055,250.00. Following the transaction, the chief executive officer now directly owns 120,481 shares of the company’s stock, valued at approximately $16,951,676.70. The trade was a 6.64 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Corporate insiders own 0.33% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in ALLE. McClarren Financial Advisors Inc. lifted its holdings in Allegion by 61.0% in the 3rd quarter. McClarren Financial Advisors Inc. now owns 190 shares of the scientific and technical instruments company’s stock worth $27,000 after purchasing an additional 72 shares during the last quarter. TD Private Client Wealth LLC raised its position in shares of Allegion by 0.4% in the third quarter. TD Private Client Wealth LLC now owns 19,697 shares of the scientific and technical instruments company’s stock valued at $2,871,000 after purchasing an additional 77 shares during the period. Greenwich Wealth Management LLC lifted its stake in shares of Allegion by 0.5% in the second quarter. Greenwich Wealth Management LLC now owns 14,908 shares of the scientific and technical instruments company’s stock worth $1,761,000 after buying an additional 79 shares during the last quarter. OneDigital Investment Advisors LLC lifted its stake in shares of Allegion by 2.9% in the third quarter. OneDigital Investment Advisors LLC now owns 2,913 shares of the scientific and technical instruments company’s stock worth $425,000 after buying an additional 82 shares during the last quarter. Finally, Thrive Wealth Management LLC boosted its holdings in shares of Allegion by 5.0% during the 3rd quarter. Thrive Wealth Management LLC now owns 1,844 shares of the scientific and technical instruments company’s stock worth $269,000 after buying an additional 88 shares during the period. Institutional investors and hedge funds own 92.21% of the company’s stock.

Allegion Company Profile

Allegion plc manufactures and sells mechanical and electronic security products and solutions worldwide. The company offers door controls and systems and exit devices; locks, locksets, portable locks, and key systems and services; electronic security products and access control systems; time, attendance, and workforce productivity systems; doors, accessories, and other.